First PI3K Inhibitor Approved for Metastatic, Advanced Breast Cancer

Piqray approved for HR - positive, HER2 - negative, PIK3CA - mutated, metastatic or advanced breast cancer
Source: The Doctors Lounge - Oncology - Category: Cancer & Oncology Tags: Oncology, FDA Approvals, Source Type: news